Jiangsu (SH:688426) Shang Hai Zheng Quan Bao·2025-05-21 19:49Meeting Overview - The annual general meeting of Jiangsu Kangwei Century Biotechnology Co., Ltd. was held on May 21, 2025, at the company's meeting room in Taizhou, Jiangsu Province [2][4] - The total share capital of the company is 112,493,716 shares, with 109,931,802 shares having voting rights after excluding shares held in the repurchase account [2] Voting and Attendance - The meeting was conducted using a combination of on-site and online voting methods, and was presided over by Mr. Qi Yubai, as the chairman was absent due to business travel [4][5] - All 9 current directors and 3 current supervisors attended the meeting, along with the company secretary and other senior executives [5][6] Resolutions Passed - Several resolutions were passed during the meeting, including: - Approval of the 2024 Board of Directors' work report [7][8] - Approval of the 2024 Supervisory Board's work report [8] - Approval of the 2024 financial settlement report [8] - Approval of the 2024 annual report and its summary [8] - Approval of the profit distribution plan for 2024 [8] - Approval of the 2025 remuneration plan for directors [8] - Approval of the 2025 remuneration plan for supervisors [8] - All resolutions were ordinary resolutions and required more than half of the voting rights held by attending shareholders or their proxies to pass [9] Legal Compliance - The meeting was witnessed by Shanghai Tongli Law Firm, confirming that the meeting's procedures and voting were in compliance with relevant laws and the company's articles of association [9]